Shizuoka, Japan

Takuya Torizawa

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 21.0

ph-index = 2

Forward Citations = 28(Granted Patents)


Company Filing History:


Years Active: 2016-2025

where 'Filed Patents' based on already Granted Patents

3 patents (USPTO):

Title: Takuya Torizawa: Innovator in Peptide-Cyclization Methods

Introduction

Takuya Torizawa is a prominent inventor based in Shizuoka, Japan. He has made significant contributions to the field of drug discovery through his innovative methods for cyclizing peptide compounds. With a total of three patents to his name, Torizawa is recognized for his expertise and dedication to advancing pharmaceutical research.

Latest Patents

Torizawa's latest patents focus on a peptide-compound cyclization method. The primary objective of this invention is to provide methods for discovering drugs that are effective for challenging targets, which have traditionally been difficult to identify. His work involves novel techniques for cyclizing peptide compounds, as well as the development of new peptide compounds and libraries that incorporate these methods.

Career Highlights

Takuya Torizawa is currently employed at Chugai Seiyaku Kabushiki Kaisha, a leading pharmaceutical company in Japan. His role at the company allows him to apply his innovative ideas and contribute to the development of new therapeutic solutions. Torizawa's work has garnered attention in the scientific community, highlighting his impact on drug discovery.

Collaborations

Torizawa collaborates with talented colleagues, including Shiori Kariyuki and Takeo Iida. These partnerships enhance the research environment and foster the exchange of ideas, further driving innovation in their field.

Conclusion

Takuya Torizawa is a key figure in the realm of peptide-cyclization methods, with a focus on drug discovery. His contributions through patents and collaborations underscore his commitment to advancing pharmaceutical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…